Valerie Morisset

CIK 1868517 · View on SEC EDGAR ↗

Insider

First SEC filing: Aug. 9, 2021 · Latest: Aug. 9, 2021

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 14 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

14 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
July 22, 2024 CLYM S 39,005 $8.07 $314,770 61,317 Direct -38.88% Disposed 112.6% (price as of 2026-08-21)
July 22, 2024 CLYM S 30,000 $7.98 $239,400 31,317 Direct -48.93% Disposed 115.0% (price as of 2026-08-21)
July 19, 2024 CLYM S 10,201 $7.09 $72,325 150,322 Direct -6.35% Disposed 142.0% (price as of 2026-08-21)
July 19, 2024 CLYM S 50,000 $7.24 $362,000 100,322 Direct -33.26% Disposed 137.0% (price as of 2026-08-21)
July 18, 2024 CLYM S 38,576 $6.93 $267,332 160,523 Direct -19.38% Disposed 147.6% (price as of 2026-08-21)
July 17, 2024 CLYM S 3,207 $6.91 $22,160 199,099 Direct -1.59% Disposed 148.3% (price as of 2026-08-21)
July 16, 2024 CLYM S 50,000 $7.13 $356,500 202,306 Direct -19.82% Disposed 140.7% (price as of 2026-08-21)
July 15, 2024 CLYM S 42,377 $7.01 $297,063 252,306 Direct -14.38% Disposed 144.8% (price as of 2026-08-21)
July 12, 2024 CLYM S 50,000 $7.07 $353,500 294,683 Direct -14.51% Disposed 142.7% (price as of 2026-08-21)
July 11, 2024 CLYM S 50,000 $7.11 $355,500 344,683 Direct -12.67% Disposed 141.3% (price as of 2026-08-21)
July 10, 2024 CLYM S 50,000 $6.83 $341,500 394,683 Direct -11.24% Disposed 151.2% (price as of 2026-08-21)
July 9, 2024 CLYM S 5,931 $6.66 $39,500 444,683 Direct -1.32% Disposed 157.6% (price as of 2026-08-21)
July 5, 2024 CLYM S 12,342 $7.06 $87,135 450,614 Direct -2.67% Disposed 143.0% (price as of 2026-08-21)
July 3, 2024 CLYM S 50,000 $6.76 $338,000 462,956 Direct -9.75% Disposed 153.8% (price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
July 1, 2024 CLYM Stock Option (Right to Buy) Common Stock (7,649) $0.00 Feb. 25, 2031 7,649 Disposed
April 5, 2024 CLYM Stock Option (Right to Buy) Common Stock (17,847) $0.00 Feb. 25, 2031 17,847 Disposed
Sept. 20, 2023 CLYM Stock Option (Right to Buy) Common Stock (5,431) $0.00 Feb. 3, 2030 5,431 Disposed
Sept. 20, 2023 CLYM Stock Option (Right to Buy) Common Stock (15,297) $0.00 Feb. 25, 2031 15,297 Disposed
March 10, 2023 CLYM Stock Option (Right to Buy) Common Stock (61,191) $0.00 Feb. 25, 2031 61,191 Disposed
March 10, 2023 CLYM Stock Option (Right to Buy) Common Stock (255,219) $0.00 Feb. 3, 2030 255,219 Disposed
Oct. 31, 2022 CLYM Stock Option (Right to Buy) Common Stock (170,000) $3.27 Oct. 30, 2032 170,000 Acquired
Jan. 27, 2022 CLYM Stock Option (Right to Buy) Common Stock (170,000) $8.21 Jan. 26, 2032 170,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 3 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
Aug. 9, 2021 CLYM Common Stock 150,322 Direct
Aug. 9, 2021 CLYM Stock Option (Right to Buy)→ Common Stock (260,650) 260,650 Direct
Aug. 9, 2021 CLYM Stock Option (Right to Buy)→ Common Stock (122,381) 122,381 Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2024 $358,066 $268,550 $1,045,075 $2,235,295
2022 $399,916 $179,962 $1,371,917 $37,987 $1,989,782
2021 $347,133 $171,830 $1,968,404 $38,354 $2,525,721

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.